trending Market Intelligence /marketintelligence/en/news-insights/trending/JSy8eqV3HtXtJ4cs_S8M1Q2 content esgSubNav
In This List

Argos Therapeutics board member resigns

Case Study

Identifying PPE Suppliers During the Pandemic


Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Argos Therapeutics board member resigns

Ralph Snyderman resigned from the board of Argos Therapeutics Inc., effective March 31.

There were no disagreements between Snyderman and the company or any officer or director of the company that led to the resignation.

Snyderman had served on the board since December 2016.